Drug Trial Radar · NCT05635045
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
Last checked: Nov 19, 2026Latest source record: Jul 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Jul 8, 2022
Primary completion
May 7, 2024
Study completion Jun 12, 2024
Sponsor
- Lead sponsor
- Columbia UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Attralus, Inc.
- First posted
- Dec 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 105 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This was a single center, prospective cohort study that is evaluating the ability of 124I-evuzamitide PET scanning to detect potential therapeutic changes in subjects under treatment for ATTR after one year had elapsed since their original 124I-evuzamitide PET scan. Ten previously scanned subjects re-consented to undergo another 124I-evuzamitide PET scan. Demographic, clinical and phenotypic data were collected to characterize potential changes since their previous scans.
Conditions
- Transthyretin Amyloidosis
Interventions
I 124-EvuzamitideDrug
Amyloid reactive protein used as imaging agent in whole body SPECT-CT imaging
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median of Uptake of Evuzamitide as Measured by Volume of Interest in MillilitersTime frame: Up to one month after imaging
- Median of Change in Evuzamitide Uptake as Measured by Percentage Change in Injected Dose (%ID)Time frame: Up to one month after imaging
- Median of Uptake of Evuzamitide as Measured by Cardiac Amyloid Activity (CAA) in GramsTime frame: Up to one month after imaging
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Columbia University Irving Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.